Shuhua Yang

Shuhua Yang, Hui Yuan, Xiaoying Zhang et al.

Conversational recommendation systems elicit user preferences by interacting with users to obtain their feedback on recommended commodities. Such systems utilize a multi-armed bandit framework to learn user preferences in an online manner and have received great success in recent years. However, existing conversational bandit methods have several limitations. First, they only enable users to provide explicit binary feedback on the recommended items or categories, leading to ambiguity in interpretation. In practice, users are usually faced with more than one choice. Relative feedback, known for its informativeness, has gained increasing popularity in recommendation system design. Moreover, current contextual bandit methods mainly work under linear reward assumptions, ignoring practical non-linear reward structures in generalized linear models. Therefore, in this paper, we introduce relative feedback-based conversations into conversational recommendation systems through the integration of dueling bandits in generalized linear models (GLM) and propose a novel conversational dueling bandit algorithm called ConDuel. Theoretical analyses of regret upper bounds and empirical validations on synthetic and real-world data underscore ConDuel's efficacy. We also demonstrate the potential to extend our algorithm to multinomial logit bandits with theoretical and experimental guarantees, which further proves the applicability of the proposed framework.

Sree Bhattacharyya, Shuhua Yang, James Z. Wang

The rapid expansion of social media platforms has provided unprecedented access to massive amounts of multimodal user-generated content. Comprehending user emotions can provide valuable insights for improving communication and understanding of human behaviors. Despite significant advancements in Affective Computing, the diverse factors influencing user emotions in social networks remain relatively understudied. Moreover, there is a notable lack of deep learning-based methods for predicting user emotions in social networks, which could be addressed by leveraging the extensive multimodal data available. This work presents a novel formulation of personalized emotion prediction in social networks based on heterogeneous graph learning. Building upon this formulation, we design HMG-Emo, a Heterogeneous Multimodal Graph Learning Framework that utilizes deep learning-based features for user emotion recognition. Additionally, we include a dynamic context fusion module in HMG-Emo that is capable of adaptively integrating the different modalities in social media data. Through extensive experiments, we demonstrate the effectiveness of HMG-Emo and verify the superiority of adopting a graph neural network-based approach, which outperforms existing baselines that use rich hand-crafted features. To the best of our knowledge, HMG-Emo is the first multimodal and deep-learning-based approach to predict personalized emotions within online social networks. Our work highlights the significance of exploiting advanced deep learning techniques for less-explored problems in Affective Computing.

Xingyu Li, Jitendra Jonnagaddala, Shuhua Yang et al.

Most early-stage colorectal cancer (CRC) patients can be cured by surgery alone, and only certain high-risk early-stage CRC patients benefit from adjuvant chemotherapies. However, very few validated biomarkers are available to accurately predict survival benefit from postoperative chemotherapy. We developed a novel deep-learning algorithm (CRCNet) using whole-slide images from Molecular and Cellular Oncology (MCO) to predict survival benefit of adjuvant chemotherapy in stage II/III CRC. We validated CRCNet both internally through cross-validation and externally using an independent cohort from The Cancer Genome Atlas (TCGA). We showed that CRCNet can accurately predict not only survival prognosis but also the treatment effect of adjuvant chemotherapy. The CRCNet identified high-risk subgroup benefits from adjuvant chemotherapy most and significant longer survival is observed among chemo-treated patients. Conversely, minimal chemotherapy benefit is observed in the CRCNet low- and medium-risk subgroups. Therefore, CRCNet can potentially be of great use in guiding treatments for Stage II/III CRC.